0000947871-14-000532.txt : 20140818
0000947871-14-000532.hdr.sgml : 20140818
20140818190358
ACCESSION NUMBER: 0000947871-14-000532
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140814
FILED AS OF DATE: 20140818
DATE AS OF CHANGE: 20140818
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: WebMD Health Corp.
CENTRAL INDEX KEY: 0001326583
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 202783228
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 EIGHTH AVE.
CITY: NEW YORK
STATE: NY
ZIP: 10011
BUSINESS PHONE: 212-624-3700
MAIL ADDRESS:
STREET 1: 111 EIGHTH AVE.
CITY: NEW YORK
STATE: NY
ZIP: 10011
FORMER COMPANY:
FORMER CONFORMED NAME: WebMD Health Holdings, Inc.
DATE OF NAME CHANGE: 20050510
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Anevski Peter
CENTRAL INDEX KEY: 0001576147
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35337
FILM NUMBER: 141050284
MAIL ADDRESS:
STREET 1: C/O WEBMD HEALTH CORP.
STREET 2: 111 EIGHTH AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 92067
4
1
ss400877_4.xml
OWNERSHIP DOCUMENT
X0306
4
2014-08-14
0
0001326583
WebMD Health Corp.
WBMD
0001576147
Anevski Peter
111 EIGHTH AVENUE
NEW YORK
NY
10011
0
1
0
0
Exec VP and CFO
Common Stock
2014-08-14
4
S
0
15000
47.60
D
54546
D
Common Stock
2014-08-15
4
M
0
30000
23.61
A
84546
D
Common Stock
2014-08-15
4
F
0
22588
48.20
D
61958
D
Common Stock
2014-08-15
4
M
0
22500
22.40
A
84458
D
Common Stock
2014-08-15
4
F
0
16669
48.19
D
67789
D
Common Stock
2014-08-15
4
M
0
32500
13.15
A
100289
D
Common Stock
2014-08-15
4
F
0
21056
48.19
D
79233
D
Common Stock
2014-08-15
4
S
0
25000
48.02
D
54233
D
Common Stock
202
I
By 401(k) Plan
Stock Option (Right to Buy)
23.61
2014-08-15
4
M
0
30000
0
D
2018-12-10
Common Stock
30000
3000
D
Stock Option (Right to Buy)
22.40
2014-08-15
4
M
0
22500
0
D
2022-05-21
Common Stock
22500
22500
D
Stock Option (Right to Buy)
13.15
2014-08-15
4
M
0
32500
0
D
2022-11-14
Common Stock
32500
32500
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.60 to $47.64 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
Mr. Anevski received 7,412 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 30,000 shares of WebMD Common Stock, with the remaining 22,588 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise.
Mr. Anevski received 5,831 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 22,500 shares of WebMD Common Stock, with the remaining 16,669 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise.
Mr. Anevski received 11,444 shares of WebMD Common Stock upon net share settlement of his exercise of options to purchase 32,500 shares of WebMD Common Stock, with the remaining 21,056 shares being retained by the issuer to pay the exercise price and to satisfy the minimum tax withholding requirements arising from the exercise.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.68 to $48.11 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5) to this Form 4.
25% of the shares underlying the option vested on each of 3/31/2010, 3/31/2011, 3/31/2012 and 3/31/2013 (fully vested on 3/31/2013). The date of grant for the options was ten years prior to the expiration date.
25% of the shares underlying the option vest on each of the first, second, third and fourth anniversaries of the date of grant (fully vested on the 4th anniversary of the grant date). The date of grant for the options was ten years prior to the expiration date.
50% of the shares underlying the option vest on each of the first and second anniversaries of the date of grant (fully vested on the 2nd anniversary of the grant date). The date of grant for the options was ten years prior to the expiration date.
/s/ Lewis H. Leicher, Attorney-in-Fact for Peter Anevski
2014-08-18